Susquehanna International Group
ISEE

Susquehanna International Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Susquehanna International Group’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-264,200
Closed -$10.4M – 13485
2023
Q2 		$10.4M Sell
264,200
-89,400
-25% -$3.16M ﹤0.01% 2463
2023
Q1 		$8.6M Buy
353,600
+157,400
+80% +$3.45M ﹤0.01% 2663
2022
Q4 		$4.2M Sell
196,200
-161,500
-45% -$3.45M ﹤0.01% 3504
2022
Q3 		$6.42M Buy
357,700
+93,900
+36% +$1.23M ﹤0.01% 2779
2022
Q2 		$2.54M Buy
263,800
+229,600
+671% +$2.88M ﹤0.01% 4402
2022
Q1 		$576K Buy
34,200
+16,300
+91% +$241K ﹤0.01% 8611
2021
Q4 		$299K Sell
17,900
-151,300
-89% -$2.48M ﹤0.01% 10509
2021
Q3 		$2.75M Buy
169,200
+109,200
+182% +$1.19M ﹤0.01% 5136
2021
Q2 		$379K Sell
60,000
-45,200
-43% -$292K ﹤0.01% 10263
2021
Q1 		$650K Buy
105,200
+38,400
+57% +$233K ﹤0.01% 8859
2020
Q4 		$462K Sell
66,800
-85,300
-56% -$546K ﹤0.01% 8462
2020
Q3 		$858K Sell
152,100
-9,700
-6% -$46.3K ﹤0.01% 6491
2020
Q2 		$825K Buy
161,800
+105,300
+186% +$439K ﹤0.01% 6322
2020
Q1 		$194K Buy
56,500
+25,700
+83% +$150K ﹤0.01% 8733
2019
Q4 		$264K Buy
+30,800
New +$110K ﹤0.01% 8254
2019
Q1 		– Sell
-12,900
Closed -$15K – 10121
2018
Q4 		$15K Sell
12,900
-8,000
-38% -$15.5K ﹤0.01% 8714
2018
Q3 		$49K Buy
20,900
+3,400
+19% +$8.47K ﹤0.01% 8856
2018
Q2 		$48K Sell
17,500
-4,400
-20% -$12.1K ﹤0.01% 9287
2018
Q1 		$60K Buy
21,900
+7,500
+52% +$21.7K ﹤0.01% 8911
2017
Q4 		$45K Sell
14,400
-17,100
-54% -$48.1K ﹤0.01% 8937
2017
Q3 		$89K Buy
31,500
+12,200
+63% +$32.9K ﹤0.01% 8395
2017
Q2 		$49K Buy
+19,300
New +$52.6K ﹤0.01% 8896
2017
Q1 		– Sell
-240,000
Closed -$1.16M – 10255
2016
Q4 		$1.16M Sell
240,000
-125,200
-34% -$3.72M ﹤0.01% 5207
2016
Q3 		$16.8M Buy
365,200
+192,300
+111% +$10.8M 0.01% 1142
2016
Q2 		$8.82M Buy
172,900
+147,600
+583% +$7.33M ﹤0.01% 1559
2016
Q1 		$1.07M Buy
25,300
+9,600
+61% +$489K ﹤0.01% 4952
2015
Q4 		$1.23M Sell
15,700
-64,500
-80% -$3.73M ﹤0.01% 5005
2015
Q3 		$3.25M Buy
80,200
+4,000
+5% +$212K ﹤0.01% 3353
2015
Q2 		$3.97M Buy
76,200
+39,200
+106% +$1.95M ﹤0.01% 3315
2015
Q1 		$1.72M Buy
37,000
+18,800
+103% +$976K ﹤0.01% 4596
2014
Q4 		$817K Sell
18,200
-28,600
-61% -$1.2M ﹤0.01% 6261
2014
Q3 		$1.82M Sell
46,800
-40,100
-46% -$1.57M ﹤0.01% 4777
2014
Q2 		$3.68M Buy
86,900
+18,400
+27% +$675K ﹤0.01% 3572
2014
Q1 		$2.45M Buy
+68,500
New +$2.31M ﹤0.01% 3987

Susquehanna International Group's ISEE Position: Q3 2023 in Review

Susquehanna International Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 94,992 shares — an estimated $3.74M sold.

Susquehanna International Group first reported a position in ISEE in Q4 2013 and held it in 35 quarters. The position peaked at $9.19M in Q1 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Susquehanna International Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Susquehanna International Group sold 94,992 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $3.74M.
  • Susquehanna International Group first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 35 quarters.
  • Susquehanna International Group's IVERIC bio, Inc. Common Stock position peaked at $9.19M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.